More recently, Smith and co-workers [20] have, however, suggested that radioiodide uptake in thyroid cancer cells could be increased and, thus, efficacy of the treatment could be improved by targeting PTTG1IP expression via the modulation of phosphorylation. Here, PTTG1IP is linked to thyroid cancer.